Page last updated: 2024-10-25

deferoxamine and Vaginitis

deferoxamine has been researched along with Vaginitis in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Vaginitis: Inflammation of the vagina characterized by pain and a purulent discharge.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Savage, KA1
Parquet, MC1
Allan, DS1
Davidson, RJ1
Holbein, BE1
Lilly, EA1
Fidel, PL1

Other Studies

1 other study available for deferoxamine and Vaginitis

ArticleYear
Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:8

    Topics: Animals; Antifungal Agents; Azoles; Candida; Candida albicans; Deferiprone; Deferoxamine; Disease Mo

2018